Quantum Chemistry Methods for Oncological Drugs
Quantum Chemistry Methods for Oncological Drugs
Albuquerque, Eudenilson L.
Elsevier - Health Sciences Division
02/2024
302
Mole
Inglês
9780443155307
15 a 20 dias
Descrição não disponível.
PART I: QUANTUM CHEMISTRY: A REVIEW
1. From classical to quantum physics (draft ready)
2. Main theoretical results
3. Computational approach
PART II: IMMUNE-ONCOLOGICAL DRUGS
4. Cancer Immunotherapy
5. Immune-oncological drug Atezolizumab
6. Immune-oncological drug Nivolumab
7. Immune-oncological drug Pembrolizumab
8. Immune-oncological drug Ipilimumab
9. Optoelectronics properties
PART III: TRANSVERSE ONCOLOGICAL DRUGS
10. Introduction
11. Oncological drugs complexed with the Human Serum Albumin (draft ready)
12. Anti- Breast cancer oncological drugs
13. Anti-Prostate cancer oncological drugs
PART IV: LOOKING AHEAD
14. The future of the oncological drugs
1. From classical to quantum physics (draft ready)
2. Main theoretical results
3. Computational approach
PART II: IMMUNE-ONCOLOGICAL DRUGS
4. Cancer Immunotherapy
5. Immune-oncological drug Atezolizumab
6. Immune-oncological drug Nivolumab
7. Immune-oncological drug Pembrolizumab
8. Immune-oncological drug Ipilimumab
9. Optoelectronics properties
PART III: TRANSVERSE ONCOLOGICAL DRUGS
10. Introduction
11. Oncological drugs complexed with the Human Serum Albumin (draft ready)
12. Anti- Breast cancer oncological drugs
13. Anti-Prostate cancer oncological drugs
PART IV: LOOKING AHEAD
14. The future of the oncological drugs
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Quantum chemistry formalism; Computational quantum chemistry; Density function theory; Quantum binding interactions; cancer therapy; Cancer immunotherapy; Immune checkpoints; Immune oncological drugs; Optoelectronics properties of oncological drugs; Human serum albumin; Breast anticancer drugs; Prostate anticancer drugs
PART I: QUANTUM CHEMISTRY: A REVIEW
1. From classical to quantum physics (draft ready)
2. Main theoretical results
3. Computational approach
PART II: IMMUNE-ONCOLOGICAL DRUGS
4. Cancer Immunotherapy
5. Immune-oncological drug Atezolizumab
6. Immune-oncological drug Nivolumab
7. Immune-oncological drug Pembrolizumab
8. Immune-oncological drug Ipilimumab
9. Optoelectronics properties
PART III: TRANSVERSE ONCOLOGICAL DRUGS
10. Introduction
11. Oncological drugs complexed with the Human Serum Albumin (draft ready)
12. Anti- Breast cancer oncological drugs
13. Anti-Prostate cancer oncological drugs
PART IV: LOOKING AHEAD
14. The future of the oncological drugs
1. From classical to quantum physics (draft ready)
2. Main theoretical results
3. Computational approach
PART II: IMMUNE-ONCOLOGICAL DRUGS
4. Cancer Immunotherapy
5. Immune-oncological drug Atezolizumab
6. Immune-oncological drug Nivolumab
7. Immune-oncological drug Pembrolizumab
8. Immune-oncological drug Ipilimumab
9. Optoelectronics properties
PART III: TRANSVERSE ONCOLOGICAL DRUGS
10. Introduction
11. Oncological drugs complexed with the Human Serum Albumin (draft ready)
12. Anti- Breast cancer oncological drugs
13. Anti-Prostate cancer oncological drugs
PART IV: LOOKING AHEAD
14. The future of the oncological drugs
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Quantum chemistry formalism; Computational quantum chemistry; Density function theory; Quantum binding interactions; cancer therapy; Cancer immunotherapy; Immune checkpoints; Immune oncological drugs; Optoelectronics properties of oncological drugs; Human serum albumin; Breast anticancer drugs; Prostate anticancer drugs